| Title : Targeting Host Glycolysis as a Strategy for Antimalarial Development - Jezewski_2021_Front.Cell.Infect.Microbiol_11_730413 |
| Author(s) : Jezewski AJ , Lin YH , Reisz JA , Culp-Hill R , Barekatain Y , Yan VC , D'Alessandro A , Muller FL , Odom John AR |
| Ref : Front Cell Infect Microbiol , 11 :730413 , 2021 |
| Abstract : |
| PubMedSearch : Jezewski_2021_Front.Cell.Infect.Microbiol_11_730413 |
| PubMedID: 34604112 |
| Title : Targeting Host Glycolysis as a Strategy for Antimalarial Development - Jezewski_2021_Front.Cell.Infect.Microbiol_11_730413 |
| Author(s) : Jezewski AJ , Lin YH , Reisz JA , Culp-Hill R , Barekatain Y , Yan VC , D'Alessandro A , Muller FL , Odom John AR |
| Ref : Front Cell Infect Microbiol , 11 :730413 , 2021 |
| Abstract : |
| PubMedSearch : Jezewski_2021_Front.Cell.Infect.Microbiol_11_730413 |
| PubMedID: 34604112 |
| Title : Targeting Host Glycolysis as a Strategy for Antimalarial Development - Jezewski_2021_Front.Cell.Infect.Microbiol_11_730413 |
| Author(s) : Jezewski AJ , Lin YH , Reisz JA , Culp-Hill R , Barekatain Y , Yan VC , D'Alessandro A , Muller FL , Odom John AR |
| Ref : Front Cell Infect Microbiol , 11 :730413 , 2021 |
| Abstract : |
| PubMedSearch : Jezewski_2021_Front.Cell.Infect.Microbiol_11_730413 |
| PubMedID: 34604112 |
| Title : An enolase inhibitor for the targeted treatment of ENO1-deleted cancers - Lin_2020_Nat.Metab_2_1413 |
| Author(s) : Lin YH , Satani N , Hammoudi N , Yan VC , Barekatain Y , Khadka S , Ackroyd JJ , Georgiou DK , Pham CD , Arthur K , Maxwell D , Peng Z , Leonard PG , Czako B , Pisaneschi F , Mandal P , Sun Y , Zielinski R , Pando SC , Wang X , Tran T , Xu Q , Wu Q , Jiang Y , Kang Z , Asara JM , Priebe W , Bornmann W , Marszalek JR , DePinho RA , Muller FL |
| Ref : Nat Metab , 2 :1413 , 2020 |
| Abstract : |
| PubMedSearch : Lin_2020_Nat.Metab_2_1413 |
| PubMedID: 33230295 |
| Title : An enolase inhibitor for the targeted treatment of ENO1-deleted cancers - Lin_2020_Nat.Metab_2_1413 |
| Author(s) : Lin YH , Satani N , Hammoudi N , Yan VC , Barekatain Y , Khadka S , Ackroyd JJ , Georgiou DK , Pham CD , Arthur K , Maxwell D , Peng Z , Leonard PG , Czako B , Pisaneschi F , Mandal P , Sun Y , Zielinski R , Pando SC , Wang X , Tran T , Xu Q , Wu Q , Jiang Y , Kang Z , Asara JM , Priebe W , Bornmann W , Marszalek JR , DePinho RA , Muller FL |
| Ref : Nat Metab , 2 :1413 , 2020 |
| Abstract : |
| PubMedSearch : Lin_2020_Nat.Metab_2_1413 |
| PubMedID: 33230295 |
| Title : An enolase inhibitor for the targeted treatment of ENO1-deleted cancers - Lin_2020_Nat.Metab_2_1413 |
| Author(s) : Lin YH , Satani N , Hammoudi N , Yan VC , Barekatain Y , Khadka S , Ackroyd JJ , Georgiou DK , Pham CD , Arthur K , Maxwell D , Peng Z , Leonard PG , Czako B , Pisaneschi F , Mandal P , Sun Y , Zielinski R , Pando SC , Wang X , Tran T , Xu Q , Wu Q , Jiang Y , Kang Z , Asara JM , Priebe W , Bornmann W , Marszalek JR , DePinho RA , Muller FL |
| Ref : Nat Metab , 2 :1413 , 2020 |
| Abstract : |
| PubMedSearch : Lin_2020_Nat.Metab_2_1413 |
| PubMedID: 33230295 |